The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical 5 compositions. "10 ---- --r 14 - - -- ----- --- -- ------ ~z ------- ------- V12 v5

Disclosed is a solid oral dosage pharmaceutical tablet comprising a first layer including at least one opioid, the first layer disposed between two adjacent controlled release layers, at least one of said adjacent controlled release layers including at least one non-opioid analgesic, wherein: a. the two adjacent controlled release layers cover substantially the entire first layer around a peripheral edge thereof, and/or b. a portion of the two adjacent controlled release layers are joined into a...

Disclosed is an oral dosage pharmaceutical tablet, comprising: a first layer including a first active agent in the form of hydrocodone, the first layer disposed between two adjacent controlled release layers, at least one of said adjacent layers including at least one second active agent comprising at least acetaminophen, the two adjacent layers covering a portion of the first layer.The disclosure also relates to: A tablet comprising: a first layer including a first active agent in the form of h...

The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical compositions.

An unoccluded oxybutynin gel fonnulation for topical application to a skin surface comprising: a therapeutically effective amount of oxybutynin